Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49.6M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
8.23M
-
Shares change
-
+3.99M
-
Total reported value, excl. options
-
$9.79M
-
Value change
-
+$4.48M
-
Put/Call ratio
-
0.01
-
Number of buys
-
20
-
Number of sells
-
-23
-
Price
-
$1.19
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2025
64 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q1 2025.
PDS Biotechnology Corp - Common (PDSB) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.23M shares
of 49.6M outstanding shares and own 16.59% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (4.42M shares), VANGUARD GROUP INC (1.51M shares), BlackRock, Inc. (488K shares), GEODE CAPITAL MANAGEMENT, LLC (438K shares), BLAIR WILLIAM & CO/IL (257K shares), UBS Group AG (251K shares), STATE STREET CORP (133K shares), COMMONWEALTH EQUITY SERVICES, LLC (92K shares), NORTHERN TRUST CORP (82.5K shares), and INSPIRION WEALTH ADVISORS, LLC (75.4K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.